3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pheochromocytoma
3
Paraganglioma
3
Meningioma
3
Prostatic Neoplasms
2
Neuroendocrine Tumors
2
Gastro-enteropancreatic neuroendocrine tumor
2
Carcinoma, Neuroendocrine
2
von Hippel-Lindau Disease
1
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Metastatic Neuroendocrine Prostate Cancer
1
Kidney Neoplasms
1
Hypertension
1
Head and Neck Neoplasms
1
Ganglioneuroma
1
Ganglioneuroblastoma
1
Breast Neoplasms
1
Adenocarcinoma, Follicular
1
Interventions
Magnetic Resonance Spectroscopy
9
Cyclophosphamide
7
X-Rays
6
Temozolomide
6
Specimen Handling
6
Phantoms, Imaging
6
Biopsy
6
Nuclear Medicine Department, Hospital
5
Etoposide
5
Nivolumab
4
Bevacizumab
4
Radiation
3
Irinotecan
3
Automobiles
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
lutetium Lu 177 dotatate
2
larotrectinib
2
ivosidenib
2
etoposide phosphate
2
erdafitinib
2
ensartinib
2
abemaciclib
2
Watchful Waiting
2
Radiotherapy
2
ONC206
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ependymoma
×
gallium Ga 68 dotatate
×
1 year
×
Clear all
No trials found.